Cargando…

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects

Detalles Bibliográficos
Autores principales:	Montali, Anna, Truglio, Gessica, Martino, Francesco, Ceci, Fabrizio, Ferraguti, Giampiero, Ciociola, Ester, Maranghi, Marianna, Gianfagna, Francesco, Iacoviello, Licia, Strom, Roberto, Lucarelli, Marco, Arca, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503631/ https://www.ncbi.nlm.nih.gov/pubmed/26176598 http://dx.doi.org/10.1371/journal.pone.0133335

Ejemplares similares

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
por: D’Erasmo, Laura, et al.
Publicado: (2021)

DNA Methylation Patterns Correlate with the Expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial Sodium Channel, ENaC) Genes
por: Pierandrei, Silvia, et al.
Publicado: (2021)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
por: Munigoti, Srinivasa P., et al.
Publicado: (2014)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Is it Time for Single-Pill Combinations in Dyslipidemia?
por: Schiele, François, et al.
Publicado: (2021)

Psychological Resilience, Cardiovascular Disease, and Metabolic Disturbances: A Systematic Review
por: Ghulam, Anwal, et al.
Publicado: (2022)

Active Demethylation of Non-CpG Moieties in Animals: A Neglected Research Area
por: Lucarelli, Marco, et al.
Publicado: (2019)

Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
por: Feinman, Richard D, et al.
Publicado: (2006)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2018)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs
por: Romandini, Alessandra, et al.
Publicado: (2023)

Association between Wakeup Frequency at Night and Atherogenic Dyslipidemia: Evidence for Sex Differences
por: Yao, Chien-An, et al.
Publicado: (2023)

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients
por: Cuomo, Gianluigi, et al.
Publicado: (2022)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
por: Lechner, Katharina, et al.
Publicado: (2020)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
por: Roy, Probin Kr, et al.
Publicado: (2023)

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
por: Butnariu, Lăcramioara Ionela, et al.
Publicado: (2023)

Pre-pandemic burnout and its changes during the COVID-19 outbreak as predictors of mental health of healthcare workers: A lesson to be learned
por: Giusti, Emanuele Maria, et al.
Publicado: (2023)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Cardiovascular disease prevention at the workplace: assessing the prognostic value of lifestyle risk factors and job-related conditions
por: Veronesi, Giovanni, et al.
Publicado: (2018)

The North Italian Longitudinal Study Assessing the Mental Health Effects of SARS-CoV-2 Pandemic on Health Care Workers—Part I: Study Design and Psychometric Structural Validity of the HSE Indicator Tool and Work Satisfaction Scale
por: Veronesi, Giovanni, et al.
Publicado: (2022)

Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
por: Tu, Powen, et al.
Publicado: (2009)

Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
por: Guasch, Alba, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_moaekaovecusfffkbfjc74jvpv